5-lipoxygenase inhibitor (University of Naples/University of Innsbruck)

N/A

Report date: 2025/01/26 19:09:26
NME

Base Information

Drug Name5-lipoxygenase inhibitor (University of Naples/University of Innsbruck)
Drug Alias NameRF-22c
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArachidonate 5-lipoxygenase inhibitors
TargetsArachidonate 5-lipoxygenase
Therapy Area/IndicationsInflammationHypersensitivityCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInflammationHypersensitivityCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A